A review of evidence that ultraviolet-B irradiance and vitamin D reduce risk for cancer

US Endocrinology

Volumn 9, Issue 1, 2013, Pages 50-54

  Grant, William B ^a  

^a Child Health Research Center   (United States)

Author keywords

Cancer; Ecological; Hill's criteria; Observational; Randomized controlled trials; Ultraviolet B; Vitamin D

Indexed keywords

EID: 84879262418     PISSN: 17583918     EISSN: 17583926     Source Type: Journal    
DOI: 10.17925/use.2013.09.01.50     Document Type: Article

References (70)

1. Garland CF, Garland FC, Do sunlight and vitamin D reduce the likelihood of colon cancer?, Int J Epidemiol, 1980;9(3):227-31.
2. Grant WB, An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation, Cancer, 2002;94(6):1867-75.
3. Grant WB, Garland CF, The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates, Anticancer Res, 2006;26(4A):2687-99.
4. Lin SW, Wheeler DC, Park Y, et al., Prospective study of ultraviolet radiation exposure and risk of cancer in the U.S, Int J Cancer, 2012;131(6):E1015-23.
5. Nelson DE, Jarman DW, Rehm J, et al., Alcohol-attributable cancer deaths and years of potential life lost in the United States, Am J Public Health, 2013;103(4):641-8.
6. Grant WB, Ecological studies of the UVB-vitamin D-cancer hypothesis; review, Anticancer Res, 2012;32(1):223-36.
7. Grant WB, Role of solar UV irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries, Dermatoendocrinol, 2012;4(2):203-11.
8. Tuohimaa P, Pukkala E, Scelo G, et al., Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanation, Eur J Cancer, 2007;43:1701-1712.
9. Mondul AM, Weinstein SJ, Männistö S, et al., Serum vitamin D and risk of bladder cancer, Cancer Res, 2010;70 9218-23.
10. Peiris AN, Bailey BA, Manning T, Relationship of vitamin D monitoring and status to bladder cancer survival in veterans, South Med J, 2013;106(2):126-30.
11. Grant WB, Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers, J Photochem Photobiol B, 2010;101(2):130-36.
12. Yang L, Veierod MB, Lof M, et al., Prospective study of UV exposure and cancer incidence among Swedish women, Cancer Epidemiol Biomarkers Prev, 2011;20(7);1358-67.
13. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE, Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study, Cancer Causes Control, 2012;23(2):363-70.
14. Epstein E, Lindqvist PG, Geppert B, Olsson H, A population-based cohort study on sun habits and endometrial cancer, Br J Cancer, 2009;101(3):537-40.
15. Tran B, Lucas R, Kimlin M, et al., Association between ambient ultraviolet radiation and risk of esophageal cancer, Am J Gastroenterol, 2012;107:1803-13.
16. Ren C, Qiu MZ, Wang DS, et al., Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer, J Transl Med, 2012;10(1):16.
17. Cheng TY, Neuhouser ML, Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction, Cancer Causes Control, 2012;23(9):1557-65.
18. Toriola AT, Surcel HM, Calypse A, et al., Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case-control study, Eur J Cancer, 2010;46(15):2799-805.
19. Tran B, Jordan SJ, Lucas RM, et al., Association between ambient ultraviolet radiation and risk of epithelial ovarian cancer, Cancer Prev Res (Phila), 2012;5(11):1330-36.
20. Wolpin BM, Ng K, Bao Y, et al., Plasma 25-hydroxyvitamin D and risk of pancreatic cancer, Cancer Epidemiol Biomarkers Prev, 2012;21(1):82-91.
21. Gilbert R, Metcalfe C, Fraser WD, et al., Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade, Int J Cancer, 2012;131(5):1187-96.
22. Salehin D, Haugk C, Thill M, et al., Serum 25-hydroxyvitamin D levels in patients with vulvar cancer, Anticancer Res, 2012;32 265-70.
23. Pukkala E, Martinsen JI, Lynge E, et al., Occupation and cancer - follow-up of 15 million people in five Nordic countries, Acta Oncol, 2009;48:646-790.
24. Garland CF, Garland FC, Gorham ED, Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates, Ann Epidemiol, 2003;13(6):395-404.
25. Lin JS, Eder M, Weinmann S, et al., Behavioral counseling to prevent skin cancer: Systematic evidence review to update the 2003 U.S. Preventive Services Task Force Recommendation [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Feb.
26. Chang YM, Barrett JH, Bishop DT, et al., Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls, Int J Epidemiol, 2009;38(3):814-30.
27. Grant WB, An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking, Int J Cancer, 2007;120(5):1123-7.
28. Grant WB, An ecological study of cancer mortality rates in California, 1950-64, with respect to solar UVB and smoking indices, Dermatoendocrinol, 2012;4(2):176-82.
29. Hill AB, The environment and disease: Association or causation?, Proc R Soc Med, 1965;58:295-300.
30. Biesalski HK, Aggett PJ, Anton R, et al., 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition, Nutrition, 2011;27(10 Suppl.):S1-20.
31. Grant WB, How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality, Dermatoendocrinol, 2009;1(1):17-24.
32. Mohr SB, Gorham ED, Alcaraz JE, et al., Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria?, Dermatoendocrin, 2012;4(2):152-7.
33. Pike JW, Meyer MB, The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3, Rheum Dis Clin North Am, 2012;38(1):13-27.
34. Pilz S, Vitamin D and cancer: current evidence and future perspective, Anticancer Agents Med Chem, 2013;13(1):2-3.
35. Grant WB, A review of the evidence regarding the solar ultraviolet-B-vitamin D-cancer hypothesis, Standardy Medyczne/ Pediatria, 2012;9:610-19.
36. Bakhru A, Mallinger JB, Buckanovich RJ, Griggs JJ, Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: A study from the NHANES, Gynecol Oncol, 2010;119(2):314-18.
37. Grant WB, Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-analyses and setting vitamin D guidelines, Dermatoendocrinol, 2011;3(3):199- 204.
38. Zehnder D, Bland R, Williams MC, et al., Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase, J Clin Endocrinol Metab, 2001;86(2):888-94.
39. Oh EY, Ansell C, Nawaz H, et al., Global breast cancer seasonality, Breast Cancer Res Treat, 2010;123(1):233-43.
40. Helzlsouer KJ, For the VDPP Steering Committee. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, Am J Epi, 2010;172:4-9.
41. Grant WB, An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption, and urban/rural residence, Dermatoendocrinol, 2010;2(2):68-76.
42. Ginde AA, Liu MC, Camargo CA Jr, Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004, Arch Intern Med, 2009;169(6):626-32.
43. Grant WB, Peiris AN, Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and White Americans, Dermatoendocrinol, 2012;4(2):85-94.
44. Grant WB, Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyitamin D and all-cause mortality rate, Dermatoendocrinol, 2012;4(2):198-202.
45. Fleet JC, Desmet M, Johnson R, Li Y, Vitamin D and cancer: a review of molecular mechanisms, Biochem J, 2012;441(1):61-76.
46. Lappe JM, Travers-Gustafson D, Davies KM, et al., Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial, Am J Clin Nutr, 2007;85(6):1586-91.
47. Bolland MJ, Grey A, Gamble GD, Reid IR, Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set, Am J Clin Nutr, 2011;94(4):1144-9.
48. Lappe JM, Heaney RP, Why randomized controlled trials of calcium and vitamin D sometimes fail, Dermatoendocrin, 2012;4(2):95-100.
49. Peterlik M, Grant WB, Cross HS, Calcium, vitamin D and cancer, Anticancer Res, 2009;29(9):3687-98.
50. Garland CF, Gorham ED, Mohr SB, Garland FC, Vitamin D for cancer prevention: Global perspective, Ann Epi, 2009;19(7): 468-83.
51. Mocellin S, Vitamin D and cancer: Deciphering the truth, Biochim Biophys Acta, 2011;1816(2):172-8.
52. Krishnan AV, Trump DL, Johnson CS, Feldman D, The role of vitamin D in cancer prevention and treatment, Rheum Dis Clin North Am, 2012;38(1):161-78.
53. Ross AC, Manson JE, Abrams SA, et al., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know, J Clin Endocrinol Metab, 2011;96(1):53-8.
54. Grant WB, Benefits of ultraviolet-B irradiance and vitamin D in youth, J Steroid Biochem Molec Bio, 2012; Epub ahead of print.
55. Armstrong B, Doll R, Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices, Int J Cancer, 1975;15(4):617-31.
56. Cho E, Chen WY, Hunter DJ, et al. Red meat intake and risk of breast cancer among premenopausal women, Arch Intern Med, 2006;166(20):2253-9.
57. Friedland RP, Nandi S, A modest proposal for a longitudinal study of dementia prevention (with apologies to Jonathan Swift, 1729), J Alzheimers Dis, 2013;33(2):313-15.
58. Grant WB, In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance. Dermatoendocrinol, 2009;1(4):207-14.
59. Jablonski NG, Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation, Proc Natl Acad Sci U S A, 2010;107 Suppl 2:8962-8.
60. Durup D, Jørgensen HL, Christensen J, et al., A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice, the CopD Study, J Clin Endocrinol Metab, 2012;97(8):2644-52.
61. Ensrud KE, Ewing SK, Fredman L, et al., Circulating 25-hydroxyvitamin D levels and frailty status in older women, J Clin Endocrinol Metab, 2010;95(12):5266-73.
62. Ensrud KE, Blackwell TL, Cauley JA, et al., Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study, J Am Geriatr Soc, 2011;59(1):101-6.
63. Zittermann A, Iodice S, Pilz S, et al., Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies, Am J Clin Nutr, 2012;95(1):91-100.
64. Anderson JL, May HT, Horne BD, et al., Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population, Am J Cardiol, 2010;106(7):963-8.
65. Vacek JL, Vanga SR, Good M, et al., Vitamin D deficiency and supplementation and relation to cardiovascular health, Am J Cardiol, 2012;109(3):359-63.
66. Afzal S, Bojesen SE, Nordestgaard BG, Low 25-hydroxyvitamin D and risk of type 2 diabetes: A prospective cohort study and metaanalysis, Clin Chem, 2013;59(2):381-91
67. Souberbielle JC, Body JJ, Lappe JM, et al, Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice, Autoimmun Rev, 2010;9(11):709-15.
68. Grant WB, An estimate of the global reduction in mortality rates through doubling vitamin D levels, Eur J Clin Nutr, 2011;65(9):1016-26.
69. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2011;96(7):1911-30.
70. Garland CF, French CB, Baggerly LL, Heaney RP, Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention, Anticancer Res, 2011;31:617-22.